Chemed Corp. Income Statement

CHE / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)

Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.

Chemed Corp. reported $2.5B in revenue and $265M in net income for FY2025. Revenue has grown at a 4.6% compound annual rate over the past 14 years.

Based on SEC 10-K filings.

Key Data Points

Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
High earnings quality (cash-backed earnings)

Data sourced from SEC EDGAR filings. Not investment advice.

Item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Revenue	$2.5B	$2.4B	$2.3B	$2.1B	$2.1B	$2.1B	$1.9B	$1.8B	$1.7B	$1.6B	$1.5B	$1.5B	$1.4B	$1.4B	$1.4B
Cost of Revenue	$1.7B	$1.6B	$1.5B	$1.4B	$1.4B	$1.4B	$1.3B	$1.2B	$1.2B	$1.1B	$1.1B	$1.0B	$1.0B	$1.0B	$970.5M
SG&A Expense	$417.2M	$424.4M	$395.1M	$358.7M	$366.7M	$330.2M	$305.7M	$271.2M	$276.7M	$243.6M	$237.8M	$222.6M	$215.6M	$208.7M	$202.3M
Operating Income	$338.2M	$366.5M	$340.6M	$343.5M	$343.0M	$389.7M	$257.4M	$243.6M	$113.0M	$178.7M	$184.5M	$168.4M	$133.4M	$156.4M	$153.7M
Interest Expense	$1.8M	$1.8M	$3.1M	$4.6M	$1.9M	$2.4M	$4.5M	$5.0M	$4.3M	$3.7M	$3.6M	$8.2M	$15.0M	$14.7M	$13.9M
Income Tax	$90.5M	$97.5M	$77.9M	$80.1M	$81.8M	$76.5M	$41.7M	$34.1M	$18.7M	$68.3M	$69.9M	$63.4M	$46.6M	$56.5M	$54.6M
Net Income	$265.2M	$302.0M	$272.5M	$249.6M	$268.6M	$319.5M	$219.9M	$205.5M	$98.2M	$108.7M	$110.3M	$99.3M	$77.2M	$89.3M	$86.0M
EPS (Basic)	$18.11	$16.72	$17.14	$20.02	$13.77	$12.80	$6.11	$6.64	$6.54	$5.79	$4.24	$4.72	$4.19	$3.62	$3.29
EPS (Diluted)	$17.93	$16.53	$16.85	$19.48	$13.31	$12.23	$5.86	$6.48	$6.33	$5.57	$4.16	$4.62	$4.10	$3.55	$3.24
Shares Outstanding	15.2M	15.1M	15.9M	16.4M	16.5M	16.8M	16.7M	16.8M	17.4M	17.8M	18.6M	19.3M	20.9M	23.0M	22.7M
Operating Margin	13.4%	15.1%	15.0%	16.1%	16.0%	18.7%	13.3%	13.7%	6.8%	11.3%	11.9%	11.6%	9.4%	10.9%	11.3%
Profit Margin	10.5%	12.4%	12.0%	11.7%	12.6%	15.4%	11.3%	11.5%	5.9%	6.9%	7.1%	6.8%	5.5%	6.2%	6.3%

Other Financial Statements

Balance Sheet Cash Flow Statement All Financial Data

Scores & Analysis

Piotroski F-Score Altman Z-Score Financial Ratios

Chemed Corp. Profile All Financial Data

Item

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

Revenue

$2.5B

$2.4B

$2.3B

$2.1B

$1.9B

$1.8B

$1.7B

$1.6B

$1.5B

$1.4B

Cost of Revenue

$1.7B

$1.6B

$1.5B

$1.4B

$1.3B

$1.2B

$1.1B

$1.0B

$970.5M

SG&A Expense

$417.2M

$424.4M

$395.1M

$358.7M

$366.7M

$330.2M

$305.7M

$271.2M

$276.7M

$243.6M

$237.8M

$222.6M

$215.6M

$208.7M

$202.3M

Operating Income

$338.2M

$366.5M

$340.6M

$343.5M

$343.0M

$389.7M

$257.4M

$243.6M

$113.0M

$178.7M

$184.5M

$168.4M

$133.4M

$156.4M

$153.7M

Interest Expense

$1.8M

$3.1M

$4.6M

$1.9M

$2.4M

$4.5M

$5.0M

$4.3M

$3.7M

$3.6M

$8.2M

$15.0M

$14.7M

$13.9M

Income Tax

$90.5M

$97.5M

$77.9M

$80.1M

$81.8M

$76.5M

$41.7M

$34.1M

$18.7M

$68.3M

$69.9M

$63.4M

$46.6M

$56.5M

$54.6M

Net Income

$265.2M

$302.0M

$272.5M

$249.6M

$268.6M

$319.5M

$219.9M

$205.5M

$98.2M

$108.7M

$110.3M

$99.3M

$77.2M

$89.3M

$86.0M

EPS (Basic)

$18.11

$16.72

$17.14

$20.02

$13.77

$12.80

$6.11

$6.64

$6.54

$5.79

$4.24

$4.72

$4.19

$3.62

$3.29

EPS (Diluted)

$17.93

$16.53

$16.85

$19.48

$13.31

$12.23

$5.86

$6.48

$6.33

$5.57

$4.16

$4.62

$4.10

$3.55

$3.24

Shares Outstanding

15.2M

15.1M

15.9M

16.4M

16.5M

16.8M

16.7M

16.8M

17.4M

17.8M

18.6M

19.3M

20.9M

23.0M

22.7M

Operating Margin

13.4%

15.1%

15.0%

16.1%

16.0%

18.7%

13.3%

13.7%

6.8%

11.3%

11.9%

11.6%

9.4%

10.9%

11.3%

Profit Margin

10.5%

12.4%

12.0%

11.7%

12.6%

15.4%

11.3%

11.5%

5.9%

6.9%

7.1%

6.8%

5.5%

6.2%

6.3%